Value, Access & Outcomes

Image from space of the horizon of Earth

The optimal path to market access is complex. You have to meet the demands of payers, meet the requirements that govern HTA submissions, and satisfy stakeholders at every turn. Lumanity illuminates a way forward. We’re the pharmaceutical market access and HEOR partner that helps you to uncover the full potential of your products so that you can demonstrate their value to stakeholders around the world.

We Can Help You:

Our Impact

50+
HTA submissions supported per year worldwide
20+
Global markets in which we’ve supported HTA submissions and evidence development
1st
Supported the first HTA submissions to NICE in I-O and CAR-T, and nearly 25% of all NICE highly specialized technology (HST) submissions to date
40+
NICE appraisal meetings in which we represented our client partners
Let's Talk

We would love to hear your challenge and discuss how our team of value, access and outcomes experts can help.

Our Team

Rebecca Hyde Chief Operating Officer and Global Practice Lead, Value Access and Outcomes
Read more about Rebecca Hyde
Ron Akehurst, Executive Chairman at Lumanity
Ron Akehurst Executive Chair, HEOR
Read more about Ron Akehurst
Richard Birnie Head of Advanced Analytics, HEOR
Read more about Richard Birnie
Photo of Somali Misra Burgess
Somali Misra Burgess Vice President, Patient-Centered Outcomes
Read more about Somali Misra Burgess
Ann-Marie Chapman
Ann-Marie Chapman Head of Insight, HEOR
Read more about Ann-Marie Chapman
Miranda Cooper, Head of Statistics, HEOR at Lumanity
Miranda Cooper Head of Statistics, HEOR
Read more about Miranda Cooper
Lisa Cox, Head of Consulting, HEOR at Lumanity
Lisa Cox Head of Consulting, HEOR
Read more about Lisa Cox
Shayna Egan Director, Patient-Centered Outcomes
Read more about Shayna Egan
Christopher J Evans President, Patient-Centered Outcomes
Read more about Christopher J Evans
Brandon Foster Director, Statistics & Psychometrics
Read more about Brandon Foster
Martha Gauthier Director and Research Leader, Patient-Centered Outcomes
Read more about Martha Gauthier
Amber Gilbert Global President, Market Access
Read more about Amber Gilbert
Dan Gladwell Chief of HTA Strategy, HEOR
Read more about Dan Gladwell
Lokho John Vice President, Evidence Evaluation and Consulting, HEOR
Read more about Lokho John
Nate Johnson Director, Patient-Centered Outcomes
Read more about Nate Johnson
Jonathan Kowalski, Executive VP, Head of US HEOR at Lumanity
Jonathan Kowalski Executive Vice President, Head of US HEOR
Read more about Jonathan Kowalski
Sallie Latimer Head of HTA & Value Communications, HEOR
Read more about Sallie Latimer
Jeff Lee, VP, US Value Strategy and Services at Lumanity
Jeff Lee Vice President, US Value Strategy and Services
Read more about Jeff Lee
Chrissy Lowry, Head of Health Economics Analysis at Lumanity
Chrissy Lowry Head of Health Economics Analysis, HEOR
Read more about Chrissy Lowry
Nancy McGee Senior Vice President, Health Policy and Public Payers
Read more about Nancy McGee
David Robinson SVP Commercial Strategy & Operations
Read more about David Robinson
Neil Roskell Chief Practice Officer, Modeling and Analytics
Read more about Neil Roskell
Manpreet Sidhu Chief Practice Officer, Value Demonstration & EEC, HEOR
Read more about Manpreet Sidhu
Nick Sullivan, Global President, HEOR at Lumanity
Nick Sullivan Global President, HEOR
Read more about Nick Sullivan
Brooke Witherspoon Senior Director of Research and Operations, Patient-Centered Outcomes
Read more about Brooke Witherspoon